// App-Quantinova.ai

4089 : External validation of a prognostic score in patients (pts) with high-grade gastrointestinal neuroendocrine carcinomas (GI-NECs).

Researchers

Presenter

  • Angela Lamarca

Principal Investigators

  • Thomas Walter

  • Marianne E. Pavel

  • Ivan Borbath

  • Patricia Freis

  • Barbara Nunez

  • Alexa Childs

  • Mairead G McNamara

  • Richard Hubner

  • Rocio Garcia-Carbonero

  • Tim Meyer

  • Jorge Barriuso

  • Juan W. Valle

Medical Centers

  • Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom

  • Department of Medical Oncology, Hospices Civils de Lyon Edouard Herriot Hospital, University of Lyon, Lyon, France

  • Charite-University Medicine Berlin, Berlin, Germany

  • Department of Gastroenterology, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium

  • Department of Medical Oncology, Hospices Civils de Lyon Edouard Herriot Hospital, University of Lyon, Lyon, France

  • Department of Medical Oncology, Doce de Octubre University Hospital, Madrid, Spain

  • Department of Medical Oncology, Royal Free London NHS Foundation Trust (ENETS Centre of Excellence), London, United Kingdom

  • Medical Oncology Department, The Christie NHS Foundation Trust, Manchester, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • UCL Cancer Institute, University College London,, London, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

Locations

  • Germany

  • Spain

  • United Kingdom

  • France

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gastrointestinal neuroendocrine carcinomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved